Achiko AG<\/a> (SWX:ACHI,
\nISIN CH0522213468) along with Regenacellx.sl, announces the completion of their
\nPhase 1 study, for the group’s patent pending, nanoparticulate DNA aptamer
\nconjugate and diagnostic testing technology, Project Gumnuts. Following a
\nsuccessful in vitro<\/i> study conducted in 2020 by the University of Rovira,
\nTarragona, Spain, the current series of studies in Spain and Indonesia were
\nconducted by ISGlobal (The Barcelona Institute for Global Health), and both
\nRiau University and Madani Pekanbaru City District Hospital, respectively.<\/p>\n
\n
<\/p>\n
The study conducted in Barcelona involved translating the
\nRovira laboratory protocol into a clinical setting using the original prototype
\nmaterials. A sample of 82 participants collected over 3 months and across a
\nrange of scenarios was compared and cross-referenced against positive and
\nnegative results obtained through RT-PCR. An initial manual read yielded a
\nresult of 80% sensitivity and 63% specificity. Subsequent application of
\nsoftware and machine learning yielded a result of 91% sensitivity and 85%
\nspecificity.<\/p>\n
\n
<\/p>\n
“We are encouraged by the progress of Project Gumnuts
\nin the field”, said Dr Michael Edel of Regenacellx.sl and Inventor of
\nProject Gumnuts. “The chemistry offers possible advantages over other
\napproaches especially in the areas of consumer experience, stability and cost
\nand we’re looking forward to the further development of the technology.”<\/p>\n
\n
<\/p>\n
The ongoing studies in Pekanbaru, Indonesia are being
\nconducted with both the original prototype conjugate (Barcelona study) and additionally
\nwith a new conjugate with applied improvements. To date, over 250 patient tests
\nhave been compared with results obtained through nasopharyngeal swabs with 20
\nto 30 more being performed each week. Using prototyping materials, the
\nIndonesian team has successfully replicated results from Spain in the field in
\nPekanbaru: test results from 64 participants initially yielded 82% sensitivity
\nand 63% specificity rates. After conducting further testing using improved
\npre-production materials and further improvements in software and machine
\nlearning, sensitivity and specificity could be improved and testing time was
\nreduced to under 15 minutes. The Company expects further gains to be made in
\nensuing months.<\/p>\n
\n
<\/p>\n
“We’re now moving quickly to get the technology into
\ntest kits and into and through approvals, and we believe that given the
\nprogress beyond the initial prototypes, we’ll be able to deliver test kits
\nwhich pass the WHO guidelines for sensitivity and specificity”, said
\nSteven Goh, CEO of Achiko AG. “We believe that as testing moves from point
\nof care to point of need, the presence of the right testing technologies with
\nthe right consumer experience, available in large quantities <\/i>and at the
\nright price point, to customers at the right time, will contribute to
\nsuccessfully responding to and overcoming the impact of Covid-19 on society and
\ndo good in this world. That is what we’re here for.”<\/p>\n
\n
<\/p>\n
\u00a0<\/p>\n
\n
<\/p>\n
The issuer is solely responsible for the content of this
\nannouncement.<\/p>\n
\n
<\/p>\n
\u00a0<\/p>\n<\/p><\/div>\n\n
Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Completion of Phase 1 testing demonstrates 91%
sensitivity and 85% specificity Further optimisation studies are currently being performed
and are expected to continue to improve results and match WHO standards Next steps are completion of regulatory approvals and
moving the technology to market as soon as possible
ZURICH, …<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[60],"tags":[],"_links":{"self":[{"href":"https:\/\/eodishasamachar.com\/en\/wp-json\/wp\/v2\/posts\/11560"}],"collection":[{"href":"https:\/\/eodishasamachar.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/eodishasamachar.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/eodishasamachar.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/eodishasamachar.com\/en\/wp-json\/wp\/v2\/comments?post=11560"}],"version-history":[{"count":0,"href":"https:\/\/eodishasamachar.com\/en\/wp-json\/wp\/v2\/posts\/11560\/revisions"}],"wp:attachment":[{"href":"https:\/\/eodishasamachar.com\/en\/wp-json\/wp\/v2\/media?parent=11560"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/eodishasamachar.com\/en\/wp-json\/wp\/v2\/categories?post=11560"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/eodishasamachar.com\/en\/wp-json\/wp\/v2\/tags?post=11560"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}